Mucoepidermoid carcinoma staging

Jump to: navigation, search

Mucoepidermoid carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mucoepidermoid Carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mucoepidermoid carcinoma staging On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mucoepidermoid carcinoma staging

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mucoepidermoid carcinoma staging

CDC on Mucoepidermoid carcinoma staging

Mucoepidermoid carcinoma staging in the news

Blogs on Mucoepidermoid carcinoma staging

Directions to Hospitals Treating Mucoepidermoid carcinoma

Risk calculators and risk factors for Mucoepidermoid carcinoma staging

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

According to the American Joint Committee on Cancer (AJCC) 7th edition, there are 6 stages of mucoepidermoid carcinoma based on the tumor size and node invasion. Each stage is assigned a letter and a number that designate the tumor size and node invasion.[1]

Staging

  • According to the American Joint Committee on Cancer (AJCC) 7th edition, there are 6 stages of mucoepidermoid carcinoma based on the tumor size and node invasion. Each stage is assigned a letter and a number that designate the tumoral size and node invasion.[1] The table below summarizes the American Joint Committee on Cancer (AJCC) staging classification.


Mucoepidermoid carcinoma staging
Adapted from American Joint Committee on Cancer (AJCC). 1998 [2]
Tumor
  • T1 - 2cm or less w/o extraparenchymal extension
  • T2 - >2cm but not greater than 4cm; and w/o extraparenchymal extension
  • T3 - >4cm or with extraparenchymal extension
  • T4a - invades skin,mandible, ear canal or facial nerve
  • T4b - invades skull base, pterygoid plates or encases carotid
Nodes
  • NX - Cannot be assessed
  • N0 - No regional lymph nodes metastasis
  • N1 - Single ipsilateral lymph node, <= 3cm in greatest dimension
  • N2
  • N2a - Single ipsilateral lymph node, 3-6 cm in greatest dimension
  • N2b - Multiple ipsilateral lymph nodes, <= 6cm in greatest dimension
  • N2c - Bilateral or contralateral lymph nodes, <= 6cm in greatest dimension
  • N3 - Lymph node(s) >6 cm in greatest dimension
Overall stage
  • I - T1 N0
  • II - T2 N0
  • III - T3 N0-1, or T1-3 N1
  • IVA - T4a N0-2, or T1-4a
  • IVB - T4b N0-3, or T1-4b N3
  • IVC - M1


References

  1. 1.0 1.1 https://en.wikibooks.org/wiki/Radiation_Oncology/Head_%26_Neck/Salivary_gland Accessed on February 17, 2016
  2. AJCC System for Staging of Benign and Malignant Salivary Gland Tumors. AJCC Accessed on February 18, 2016

Linked-in.jpg